Skip to main content
. 2009;11(6):344–352. doi: 10.4088/PCC.08m00744gre

Table 2.

Antidepressant Therapy Assignment of Patients With Major Depressive Disorder Receiving Adjunctive Aripiprazole or Adjunctive Placebo (safety sample)

Antidepressant Therapy Placebo (n = 366) Aripiprazole (n = 371)
Escitalopram
 n (%) 102 (27.9) 118 (31.8)
 Dose, mean ± SE (mg) 19.3 ± 0.3 19.7 ± 0.1
Fluoxetine
 n (%) 54 (14.8) 53 (14.3)
 Dose, mean ± SE (mg) 37.8 ± 0.9 39.6 ± 0.4
Paroxetine controlled release
 n (%) 28 (7.7) 31 (8.4)
 Dose, mean ± SE (mg) 46.9 ± 1.0 48.4 ± 0.8
Sertraline
 n (%) 77 (21.0) 69 (18.6)
 Dose, mean ± SE (mg) 143.5 ± 1.9 140.6 ± 2.6
Venlafaxine extended release
 n (%) 105 (28.7) 100 (27.0)
 Dose, mean ± SE (mg) 214.3 ± 2.6 213.8 ± 2.7